Lucigen Corp:企業の製品パイプライン分析2018

【英語タイトル】Lucigen Corp - Product Pipeline Analysis, 2018 Update

GlobalDataが出版した調査資料(DATA904C12218)・商品コード:DATA904C12218
・発行会社(調査会社):GlobalData
・発行日:2018年12月
・ページ数:32
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vectors, and protein expression. It also offers CloneSmart, BigEasy Linear, DNATerminator End Repair Kit, CloneDirect Rapid Ligation Kit, UltraClone DNA Ligation and Transformation Kits, Gel-Ready DNA Ladders, NxGen Exonuclease I, NxGen Lambda Exonuclease and Pyrophosphatase, among others. The company offers next gen sequencing services such as DNA-specific sequencing services and RNA-specific sequencing services. Lucigen is headquartered in Middleton, Wisconsin, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Lucigen Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Lucigen Corp Company Overview 4
Lucigen Corp Company Snapshot 4
Lucigen Corp Pipeline Products and Ongoing Clinical Trials Overview 4
Lucigen Corp – Pipeline Analysis Overview 7
Lucigen Corp – Key Facts 7
Lucigen Corp – Major Products and Services 8
Lucigen Corp Pipeline Products by Development Stage 10
Lucigen Corp Pipeline Products Overview 12
ClariLight C. difficile 12
ClariLight C. difficile Product Overview 12
ClariLight C.difficile – CLIA Waiver 13
ClariLight C.difficile – CLIA Waiver Product Overview 13
ClariLight Influenza A and B 14
ClariLight Influenza A and B Product Overview 14
Diagnostic Assay – Ebola Virus (EBoV) test 15
Diagnostic Assay – Ebola Virus (EBoV) test Product Overview 15
Diagnostic Assay – Lassa virus 16
Diagnostic Assay – Lassa virus Product Overview 16
Diagnostic Assay – Marburg Virus 17
Diagnostic Assay – Marburg Virus Product Overview 17
Diagnostic Assay – Respiratory Syncytial virus (RSV) A and B 18
Diagnostic Assay – Respiratory Syncytial virus (RSV) A and B Product Overview 18
Diagnostic Test – Crimean-Congo Hemorrhagic Virus (CCHF) 19
Diagnostic Test – Crimean-Congo Hemorrhagic Virus (CCHF) Product Overview 19
Diagnostic Test – Staphylococcus aureus 20
Diagnostic Test – Staphylococcus aureus Product Overview 20
Diagnostic Test – West Nile Virus (WNV) 21
Diagnostic Test – West Nile Virus (WNV) Product Overview 21
Point-Of-Care Device – Arboviruses 22
Point-Of-Care Device – Arboviruses Product Overview 22
Point-Of-Care Device – HPV 23
Point-Of-Care Device – HPV Product Overview 23
Lucigen Corp – Key Competitors 24
Lucigen Corp – Key Employees 25
Lucigen Corp – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Lucigen Corp, Recent Developments 27
Sep 20, 2017: Patent for the pJAZZ System, useful for cloning challenging DNA, granted to Lucigen 27
Dec 15, 2015: Lucigen Continues Strong Quality Performance with ISO 13485 Certification 27
May 05, 2015: Lucigen Expands Technological Reach with Exclusive Sigma-Aldrich Distribution Agreement 27
Oct 29, 2014: Lucigen Announces Ralph Kauten as CEO 27
May 23, 2012: Lucigen Corporation Receives $2.8m SBIR Grant From NIH For Lucigen Influenza A, B & RSV test 28
Apr 16, 2012: Lucigen Relocates To New Facility 28
Appendix 29
Methodology 29
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Lucigen Corp Pipeline Products and Ongoing Clinical Trials Overview 4
Lucigen Corp Pipeline Products by Equipment Type 5
Lucigen Corp Pipeline Products by Indication 6
Lucigen Corp, Key Facts 7
Lucigen Corp, Major Products and Services 8
Lucigen Corp Number of Pipeline Products by Development Stage 10
Lucigen Corp Pipeline Products Summary by Development Stage 11
ClariLight C. difficile - Product Status 12
ClariLight C. difficile - Product Description 12
ClariLight C.difficile - CLIA Waiver - Product Status 13
ClariLight C.difficile - CLIA Waiver - Product Description 13
ClariLight Influenza A and B - Product Status 14
ClariLight Influenza A and B - Product Description 14
Diagnostic Assay - Ebola Virus (EBoV) test - Product Status 15
Diagnostic Assay - Ebola Virus (EBoV) test - Product Description 15
Diagnostic Assay - Lassa virus - Product Status 16
Diagnostic Assay - Lassa virus - Product Description 16
Diagnostic Assay - Marburg Virus - Product Status 17
Diagnostic Assay - Marburg Virus - Product Description 17
Diagnostic Assay - Respiratory Syncytial virus (RSV) A and B - Product Status 18
Diagnostic Assay - Respiratory Syncytial virus (RSV) A and B - Product Description 18
Diagnostic Test - Crimean-Congo Hemorrhagic Virus (CCHF) - Product Status 19
Diagnostic Test - Crimean-Congo Hemorrhagic Virus (CCHF) - Product Description 19
Diagnostic Test - Staphylococcus aureus - Product Status 20
Diagnostic Test - Staphylococcus aureus - Product Description 20
Diagnostic Test - West Nile Virus (WNV) - Product Status 21
Diagnostic Test - West Nile Virus (WNV) - Product Description 21
Point-Of-Care Device - Arboviruses - Product Status 22
Point-Of-Care Device - Arboviruses - Product Description 22
Point-Of-Care Device - HPV - Product Status 23
Point-Of-Care Device - HPV - Product Description 23
Lucigen Corp, Key Employees 25
Glossary 31

List of Figures
Lucigen Corp Pipeline Products by Equipment Type 5
Lucigen Corp Pipeline Products by Development Stage 10

★調査レポート[Lucigen Corp:企業の製品パイプライン分析2018] (コード:DATA904C12218)販売に関する免責事項を必ずご確認ください。
★調査レポート[Lucigen Corp:企業の製品パイプライン分析2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆